NCT05069324View on ClinicalTrials.gov

PegvisOMant and the Immune SystEm (PROMISE)

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

July 29, 2020

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2024

Conditions
Acromegaly
Trial Locations (1)

00161

"Department of Experimental Medicine, Sapienza University of Rome", Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT05069324 - PegvisOMant and the Immune SystEm (PROMISE) | Biotech Hunter | Biotech Hunter